Background: we previously demonstrated a markedly decreased adrenergic tone in newly diagnosed acromegalic patients by direct measurement of muscle sympathetic nerve activity (MSNA), in spite of insulin resistance (Seravalle et al., Clin Endocrinol 77:262, 2012). Our data pointed to a phenomenon mediated by hypoleptinaemia rather than a direct action of the GH-IGF-I system. Aim: It has been shown that centrally administered somatostatin (SS) inhibits peripheral sympathetic outflow in rodents (Rettig et al., Am J Physiol 257:R588, 1989). Based on the above, we elected to study MSNA in acromegalic patients before and during treatment with SS analogues (SSA)
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